Clinical trial
Trial of pDNA CMV Vaccine (VCL-CT02) Followed by Towne CMV Vaccine (Towne)…
NCT00373412 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00373412 |
|---|---|
| Title | Trial of pDNA CMV Vaccine (VCL-CT02) Followed by Towne CMV Vaccine (Towne) Challenge |
| Official title | Randomized, Phase 1 Trial to Evaluate Safety and CMV-Specific Immune Response to a pDNA CMV Trivalent Vaccine (VCL-CT02) Followed by Towne CMV Vaccine (Towne) Challenge in Healthy, CMV- Seronegative Adults |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | Vical Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cytomegalovirus Infection |
| Intervention type | Biological |
| Interventions | VCL CT02 pDNA vaccine, Towne CMV vaccine |
| Enrollment | 16 |
| Start date | Oct 1, 2006 |
| Primary completion | Feb 1, 2008 |
| First posted | Sep 8, 2006 |
| Last update posted | May 8, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: